Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level?

By Bala M.V.  

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 495-498

Adis International

Access to resources Recommend Favorite

An introduction to cost-effectiveness and cost–benefit analysis of pharmacogenomics

By Phillips Kathryn A   Veenstra David   Bebber Stephanie Van   Sakowski Julie  

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 231-239

Future Medicine

Access to resources Recommend Favorite

The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics

By Flowers C.R.   Veenstra D.  

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 481-493

Adis International

Access to resources Recommend Favorite

Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems?

By Adam La Caze  

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 445-447

Adis International

Access to resources Recommend Favorite